France vs Heavily indebted poor countries (HIPC): Immunization, HepB3
Immunization, HepB3 over time
- France
- Heavily indebted poor countries (HIPC)
How they compare
France currently reports 96.0% against 73.9% in Heavily indebted poor countries (HIPC), a difference of 22.1%.
That makes France's figure about 1.3 times Heavily indebted poor countries (HIPC)'s.
The two have swapped places 4 times across 27 shared years of data; in 1998 it was France ahead.
France ranks 42nd and Heavily indebted poor countries (HIPC) ranks 44th of 188 countries.
Across the 4 decades both report, France averaged higher in 3 and Heavily indebted poor countries (HIPC) in 1.
Head to head by decade
| Decade | France | Heavily indebted poor countries (HIPC) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 25.5% | 0.6% | 24.9% | France |
| 2000s | 36.0% | 38.0% | 2.0% | Heavily indebted poor countries (HIPC) |
| 2010s | 83.2% | 76.1% | 7.1% | France |
| 2020s | 95.8% | 73.9% | 21.9% | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, France or Heavily indebted poor countries (HIPC)?
- France, at 96.0% against 73.9% in Heavily indebted poor countries (HIPC) as of 2024.
- What is the difference in immunization, hepb3 between France and Heavily indebted poor countries (HIPC)?
- 22.1%, with France ahead.
- How many years of comparable data are there for France and Heavily indebted poor countries (HIPC)?
- 27 years are reported by both, from 1998 to 2024.
- How do France and Heavily indebted poor countries (HIPC) rank globally for immunization, hepb3?
- France ranks 42nd and Heavily indebted poor countries (HIPC) ranks 44th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.